Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BDR who wrote (6481)	5/6/1999 11:51:00 PM
From: BigKNY3	of 7041

Dale <<"VASOMAX is currently under review at the FDA; the PDUFA (user fee) deadline is July 14, 1999. However, an amendment to the original NDA submission was filed in January 1999, which could extend the user fee deadline.">> Dale: Under the User Fee Agreement with the pharmaceutical industry, the FDA is required to inform Schering the status of the Vasomax NDA by 7/14/99 (one year after the submission). However, since additional data was apparently submitted in January 1999, this deadline may be extended up to January 2000. BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next